OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolic disorder in Alzheimer’s disease
Mrinal K. Poddar, Soumyabrata Banerjee, Apala Chakraborty, et al.
Metabolic Brain Disease (2021) Vol. 36, Iss. 5, pp. 781-813
Closed Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

The mechanism and efficacy of GLP-1 receptor agonists in the treatment of Alzheimer’s disease
Haiyang Du, Xiaoyu Meng, Yao Yu, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 48

Tauroursodeoxycholic acid: a bile acid that may be used for the prevention and treatment of Alzheimer’s disease
Honghu Song, Jiancheng Liu, Linjie Wang, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 9

The Role of Sirtuin 1 in Ageing and Neurodegenerative Disease: A Molecular Perspective
Riya Thapa, Ehssan Moglad, Muhammad Afzal, et al.
Ageing Research Reviews (2024) Vol. 102, pp. 102545-102545
Closed Access | Times Cited: 9

Targeting the molecular web of Alzheimer’s disease: unveiling pathways for effective pharmacotherapy
Devika Jadhav, Nikita Saraswat, Neeraj S. Vyawahare, et al.
The Egyptian Journal of Neurology Psychiatry and Neurosurgery (2024) Vol. 60, Iss. 1
Open Access | Times Cited: 8

Symptoms and conventional treatments of Alzheimer's disease
Mehul R. Chorawala, Aayushi C. Shah, Aanshi J. Pandya, et al.
Elsevier eBooks (2024), pp. 213-234
Closed Access | Times Cited: 8

Association between depression and diabetes mellitus and the impact of their comorbidity on mortality: Evidence from a nationally representative study
Jingda Cai, Songyan Zhang, Renrong Wu, et al.
Journal of Affective Disorders (2024) Vol. 354, pp. 11-18
Closed Access | Times Cited: 8

Aberrant energy metabolism in Alzheimer’s disease
Linjie Yu, Jiali Jin, Yun Xu, et al.
Journal of Translational Internal Medicine (2022) Vol. 10, Iss. 3, pp. 197-206
Open Access | Times Cited: 29

Investigating the neuroprotective effects of Dracocephalum moldavica extract and its effect on metabolomic profile of rat model of sporadic Alzheimer's disease
Marjan Talebi, Seyed Abdulmajid Ayatollahi, Mohammad Ali As’habi, et al.
Heliyon (2025) Vol. 11, Iss. 3, pp. e42412-e42412
Open Access

The Role of the Urea Cycle in the Alzheimer's Disease Brain
Najlaa Al‐Thani, Gavin Stewart, Derek A. Costello
Journal of Neurochemistry (2025) Vol. 169, Iss. 3
Open Access

Dual orexin receptor antagonists as promising therapeutics for Alzheimer’s disease
Sydney M. Ragsdale, John M. Radovich, Isabel I. Coiduras, et al.
Deleted Journal (2025) Vol. 2, Iss. 1
Open Access

Identification of metabolism-related subtypes and feature genes in Alzheimer’s disease
Piaopiao Lian, Xing Cai, Cailin Wang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 11

Association of metabolic dysfunction with cognitive decline and Alzheimer's disease: A review of metabolomic evidence
Meysam Amidfar, Gholamreza Askari, Yong‐Ku Kim
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2023) Vol. 128, pp. 110848-110848
Closed Access | Times Cited: 10

Adipose tissue as a therapeutic target for vascular damage in Alzheimer's disease
Miriam Bettinetti‐Luque, Laura Trujillo‐Estrada, Eduardo García‐Fuentes, et al.
British Journal of Pharmacology (2023) Vol. 181, Iss. 6, pp. 840-878
Open Access | Times Cited: 10

Neuroprotective Effects of Dehydroepiandrosterone and Hericium erinaceus in Scopolamine-induced Alzheimer’s Diseases-like Symptoms in Male Rats
Majid Shirvani, Fatemeh Nouri, Abodrahman Sarihi, et al.
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 3, pp. 2853-2864
Closed Access | Times Cited: 3

Neurodegeneration: Diagnosis, Prevention, and Therapy
Mrinal K. Poddar, Apala Chakraborty, Soumyabrata Banerjee
IntechOpen eBooks (2021)
Open Access | Times Cited: 20

Machine learning models to select potential inhibitors of acetylcholinesterase activity from SistematX: a natural products database
Chonny Herrera‐Acevedo, Camilo Perdomo‐Madrigal, Kenyi Herrera-Acevedo, et al.
Molecular Diversity (2021)
Closed Access | Times Cited: 18

Metabolic Pathway Pairwise-Based Signature as a Potential Non-Invasive Diagnostic Marker in Alzheimer’s Disease Patients
Yunwen Feng, Xingyu Chen, Xiaohua Douglas Zhang, et al.
Genes (2023) Vol. 14, Iss. 6, pp. 1285-1285
Open Access | Times Cited: 7

Urine metabolomics phenotyping and urinary biomarker exploratory in mild cognitive impairment and Alzheimer’s disease
Yuye Wang, Yu Sun, Yu Wang, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 7

SOX2 modulated astrocytic process plasticity is involved in arsenic-induced metabolic disorders
Zhixin He, Yu‐Dong Xu, Qinlong Ma, et al.
Journal of Hazardous Materials (2022) Vol. 435, pp. 128942-128942
Closed Access | Times Cited: 8

Dual Orexin Receptor Antagonists as Promising Therapeutics for Alzheimer’s Disease
Sydney M. Ragsdale, Jenna Radovich, Isabel I. Coiduras, et al.
(2024)
Open Access | Times Cited: 1

Urinary and faecal metabolic characteristics in APP/PS1 transgenic mouse model of Alzheimer's disease with and without cognitive decline
Yafei Zheng, Qingqing Xu, Qihao Jin, et al.
Biochemical and Biophysical Research Communications (2022) Vol. 604, pp. 130-136
Closed Access | Times Cited: 6

Page 1 - Next Page

Scroll to top